Generic Co. Lobs Antitrust Suit To Access Brand-Name Meds

Law360, New York (April 1, 2013, 6:33 PM EDT) -- Generic-drug maker Accord Healthcare Inc. on Monday sued Acorda Therapeutics Inc. in Florida federal court for allegedly trying to stave off competition by refusing to sell samples of multiple sclerosis drug Ampyra to rival companies looking to introduce a lower-cost version of the medicine.

Accord, a unit of Indian drugmaker Intas Pharmaceuticals Ltd., is aiming to apply for U.S. Food and Drug Administration approval in January and says it needs to acquire samples by next month if it’s going to meet that target.

No generic version...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.